BCWM
BMY.RT

Bartlett & Co Wealth Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bartlett & Co Wealth Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-550
Closed -$380 – 1228
2020
Q4 		$380 Hold
550
– – ﹤0.01% 1172
2020
Q3 		$1.24K Hold
550
– – ﹤0.01% 802
2020
Q2 		$1.97K Hold
550
– – ﹤0.01% 789
2020
Q1 		$2.09K Buy
550
+330
+150% +$1.09K ﹤0.01% 775
2019
Q4 		$662 Buy
+220
New +$572 ﹤0.01% 838

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Bartlett & Co Wealth Management's BMY.RT Position: Q1 2021 in Review

Bartlett & Co Wealth Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 550 shares — an estimated $380 sold.

Bartlett & Co Wealth Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $2.09K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Bartlett & Co Wealth Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 550 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $380.
  • Bartlett & Co Wealth Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Bartlett & Co Wealth Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $2.09K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2021, filed 14 Feb 2024.